RANI - Rani Therapeutics GAAP EPS of -$0.31 beats by $0.06 August, 10 2022 05:48 PM Rani Therapeutics Holdings Inc. Rani Therapeutics press release ( NASDAQ: RANI ): Q2 GAAP EPS of -$0.31 beats by $0.06 . Cash and cash equivalents as of June 30, 2022 were $97.2M, compared to $117.5M for the year ended December 31, 2021. For further details see: Rani Therapeutics GAAP EPS of -$0.31 beats by $0.06